About EBI
Our
background
and mission
An Unmet Need
Postoperative complications
and hospital
length-of-stay
Products
Polypeptides derived from the human pregnancy hormone, reducing duration of postoperative complications
In the pipeline
Duration of postoperative complications, acute systemic inflammation & more
Clinical evidence
Phase III studies have
commenced following
positive Phase II results
Partnering
Leveraging
internal & external
expertise
EBI is developing a novel class of therapeutics
Our therapeutics are designed to specifically address the duration of postoperative complications in patients undergoing major surgery.
POSTOPERATIVE COMPLICATIONS
There is a significant unmet medical need for fast-acting drugs that address surgical stress and microvascular barrier dysfunction in patients undergoing major surgery in order to reduce the duration of postoperative complications and reduce length-of-stay at hospital and intensive care units.
Polypeptides derived from human pregnancy hormone
EBI’s lead product is based on a polypeptide derived from the human pregnancy hormone that targets vascular permeability.
Pipeline
EBI first develops its lead product as a therapeutic for reducing the duration of postoperative complications by addressing surgical stress and microvascular barrier dysfunction in major surgeries. Future indications include acute systemic inflammation and tissue damage after irradiation treatment.
Clinical evidence
EBI’s lead product is based on one of several proprietary polypeptide compounds derived from the human pregnancy hormone and is currently progressing through the clinical development phases. Phase III studies have commenced following positive Phase II results.
Our partners
EBI’s management team collaborates closely with its Scientific Advisory Board and external advisors to leverage their expertise for the full development of EBI’s product pipeline. EBI actively engages in new partnerships to successfully bring this product to the market.
Contact
Contact us for more information or to discuss business or partnering opportunities.